November 19, 20240 Comments

RFK Jr. is Trump pick for HHS secretary. Here’s what he could do

Independent presidential candidate Robert F. Kennedy Jr. makes an announcement on the future of his campaign in Phoenix, Arizona, U.S. August 23, 2024.  Thomas Machowicz | Reuters President-elect Donald Trump has tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services – a selection that is raising fears in the public health community and leaving the biotech and pharmaceutical industries bracing for disruptions to drug development.

Read More
November 19, 20240 Comments

Medtech less exposed to potential negative headlines from RFK Jr., says BofA By Investing.com

Investing.com — Bank of America analysts see the potential for medtech stocks to continue gaining momentum as they appear less vulnerable to potential healthcare-related controversies tied to RFK Jr. headlines. The bank notes that recent developments have bolstered the sector, with medtech rebounding from historically low valuations to trade more closely in line with its 10-year average discount to the Tools sector. In just two days, medtech’s discount to Tools narrowed

Read More
November 16, 20240 Comments

Trump picks RFK Jr. for Health and Human Services secretary

President-elect Donald Trump said Thursday that he will nominate vaccine skeptic and conspiracy theorist Robert F. Kennedy Jr. as secretary of the Health and Human Services Department. If the Senate approves Kennedy, the former independent presidential candidate will lead a sprawling department responsible for the huge Medicare and Medicaid health coverage programs, the Food and Drug Administration, the National Institutes of Health, and the Centers for Disease Control and Prevention.

Read More
November 15, 20240 Comments

Health stocks hit after Trump taps RFK Jr for top regulator post

Shares in vaccine makers and healthcare firms around the world slid sharply on Friday, as investors warned that Donald Trump’s choice of Robert F Kennedy Jr as US Health Secretary could pose new challenges to the sector. Kennedy is known as a vaccine sceptic and, if confirmed in the post, has vowed to use it to crack down on “Big Pharma”. The news prompted a sell-off across the industry. In

Read More
November 15, 20240 Comments

Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS

Robert F. Kennedy Jr. in Phoenix on Aug. 23, 2024. Thomas Machowicz | Reuters Shares of vaccine makers fell Thursday as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human Services.  The stocks fell in the final hour of trading as reports emerged about Trump’s expected pick. Moderna‘s stock closed more than 5% lower on Thursday, shares of Novavax

Read More
November 10, 20240 Comments

What Trump’s health pick RFK Jr. could mean for patients, drugmakers

Republican presidential nominee, former U.S. President Donald Trump welcomes Robert F. Kennedy Jr. to the stage at a Turning Point Action campaign rally at the Gas South Arena on October 23, 2024 in Duluth, Georgia.  Anna Moneymaker | Getty Images News | Getty Images Donald Trump has made one clear promise about who could help take up the government’s health reins during his second term as president: notorious vaccine skeptic

Read More